This combination pairs a GHRH analogue with a selective growth hormone secretagogue. CJC-1295 (without DAC) stimulates the pituitary to release growth hormone, while Ipamorelin does the same through a separate ghrelin-receptor pathway. Research has examined the synergistic effect of combining both pathways to produce a more robust and sustained growth hormone pulse, with studies focused on body composition, recovery, and metabolic function.
For research use only. Not intended for human or animal consumption. Not evaluated by the FDA.
This combination pairs a GHRH analogue with a selective growth hormone secretagogue. CJC-1295 (without DAC) stimulates the pituitary to release growth hormone, while Ipamorelin does the same through a separate ghrelin-receptor pathway. Research has examined the synergistic effect of combining both pathways to produce a more robust and sustained growth hormone pulse, with studies focused on body composition, recovery, and metabolic function.
For research use only. Not intended for human or animal consumption. Not evaluated by the FDA.
Image 1 of 2
Image 2 of 2